Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC (MIC:GEMA) LT-Debt-to-Total-Asset: 0.19 (As of Dec. 2023)


MIC:GEMA Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC MIC:GEMA
17 GF Score
Price ₽111.00
View Full Analysis

What is Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC LT-Debt-to-Total-Asset?

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC MIC:GEMA 17 LT-Debt-to-Total-Asset is 0.19 as of Dec. 2023. GuruFocus rates MIC:GEMA with a GF Score™ of 17/100.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's long-term debt to total assests ratio for the quarter that ended in Dec. 2023 was 0.19.

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's long-term debt to total assets ratio declined from Sep. 2022 (0.25) to Dec. 2023 (0.19). It may suggest that Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC is progressively becoming less dependent on debt to grow their business.

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC  (MIC:GEMA) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC LT-Debt-to-Total-Asset Related Terms

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC LT-Debt-to-Total-Asset Chart

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial 0.06 0.09 0.09 0.00 0.19

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.25 0.00 0.17 0.17 0.19
MIC:GEMA
17GF Score
Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC MIC:GEMA
LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC LT-Debt-to-Total-Asset Calculation

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )=Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )/Total Assets (A: Dec. 2023 )
=245.688/1277.808
=0.19

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (Q: Dec. 2023 )=Long-Term Debt & Capital Lease Obligation (Q: Dec. 2023 )/Total Assets (Q: Dec. 2023 )
=245.688/1277.808
=0.19

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →
What does a LT-Debt-to-Total-Asset of 0.19 mean?
Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC (MIC:GEMA) has a LT-Debt-to-Total-Asset of 0.19 as of Dec. 2023. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC and its competitors.
Is Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's LT-Debt-to-Total-Asset too high?
Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's current LT-Debt-to-Total-Asset is 0.19. Overall, Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's LT-Debt-to-Total-Asset compare to FICO and SPSC?
Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's LT-Debt-to-Total-Asset of 0.19 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for a Healthcare Providers & Services company?
A good LT-Debt-to-Total-Asset depends on the Healthcare Providers & Services industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC and its competitors. Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's current LT-Debt-to-Total-Asset is 0.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC stock overvalued right now?
Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC (MIC:GEMA) has a current LT-Debt-to-Total-Asset of 0.19. The current LT-Debt-to-Total-Asset is 0.19. Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's overall GF Score™ is 17/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC (MIC:GEMA), the current LT-Debt-to-Total-Asset is 0.19 as of Dec. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC Business Description

Address Ulitsa Gubkina, d. 3, Building 1, Floor 1, Moscow, RUS, 119333
Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC, through its subsidiary, is engaged in offering personal storage of cord blood stem cells in Russia and Eastern Europe. The services provided by the company include Cord Blood Cell Preservation, Program for the treatment of Cerebral Palsy, Cord Blood DNA isolation, and Umbilical Cord tissue, among others.
17GF Score

Get the complete analysis for MIC:GEMA

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₽111.00
Price